Down the Regulatory Rabbit Hole

05 Oct, 2020 Mark Pew

                               

I have the privilege of being on a panel with Lisa Anne Bickford (Director of Government Relations, Coventry) and Don Lipsy (AVP, Managed Care Government Relations, Sedgwick) at the National Workers’ Compensation and Disability virtual conference on October 21. Our session, scheduled for 2:00-3:00pm ET, is entitled “Workers' Comp Regulatory and Legislative Trends that Belong on Your Radar for 2021.” Lisa, Don and I became friends over several years as we worked together on initiatives around the country so our session will be as though we are at a restaurant catching up on what’s new.

Instead of specific bills or regulations, we are going to focus on five key areas that have had major activity in the recent past, the current and into the future: pharmaceuticals, telehealth, BioPsychoSocial treatment model, presumptions and employee classification. Unsurprisingly (if you know us), each of us have an opinion on each subject and so the hour (that will include live audience Q&A at the end) will most definitely fly by. Hopefully my thoughts below will entice you to attend:

Pharmaceuticals: Treatment guidelines – in work comp and with other payers – have evolved on prescription opioids (and other painkillers) since Washington state created their proprietary drug formulary in 2004. Because of that, and other external forces, prescribing patterns have changed (“NSAIDs, often prescribed as non-opioid alternatives to treat pain, surpassed opioids as the top drug group in California workers’ compensation in 2016”). There was a very specific need for drug formularies in work comp. Question: Will more be enacted?

Telehealth: There was progress towards acceptance of telemedicine, by employers and employees, prior to March. However, because of COVID-19, “we saw 10 years of telehealth adoption in about 8 weeks” as the healthcare opportunity increased from $3 billion to $250 billion and regulations from Medicare to work comp were relaxed. There is widespread hope that the momentum continues. Question: What happens next?

BioPsychoSocial treatment model: “Psych” is not nearly as scary to the work comp industry in 2020 as it was in 2010. However, there are geographical and generational differences in adoption by payer, provider and patient so we still aren’t where we need to be in implementing a whole-person approach to recovery. COVID-19 has been a game-changer because the importance of mental health in relation to resilience has become a personal issue for every human being on planet earth. Question: What could stop progress?

Presumptions: The expansion of presumptively compensable work comp claims, originally focused on first responders and now including “essential workers” related to COVID-19, is both an important and emotional discussion. It is difficult to argue that PTSD for police officers or respiratory issues for firefighters are not related to their job duties. However, this creates different standards based on job classification (so there is effectively multiple work comp “systems”) and unfunded liabilities for municipalities with revenue shortfall due to shelter-in-place. Question: Is this sustainable?

Employee classification: The “gig economy” is the preferred choice of income for millions of Americans for the flexibility it provides (often individuals have multiple concurrent “gigs” that they work on their own hours and at their own pace). Government – specifically California with AB5 but other states that are also using the ABC test – is questioning where the line of employment is drawn. This changes the business model of these companies from independent contractors to employees. However you believe these workers should be categorized, there is no denying that the viability of the companies and income for millions of Americans will be negatively impacted. Question: What is the cost of change?

We may end up with more questions than answers but that so perfectly fits 2020. Hope to “see” you there!

By Mark Pew

Mark Pew, senior vice president of product development and marketing for Preferred Medical, is a passionate educator and agitator. Mark is a recognized thought leader in workers’ compensation and award-winning speaker, blogger, author and jurisdictional advisor. Also known as the RxProfessor, he is focused on the intersection of chronic pain and appropriate treatment, particularly as it relates to the clinical and financial implications of prescription painkillers, non-pharma treatment modalities and the evolution of medical marijuana. He is a strong champion for the industry to #PreventTheMess and #CleanUpTheMess with a specific focus on the BioPsychoSocialSpiritual treatment model.


  • AI california case management case management focus claims cms compensability compliance conferences courts covid do you know the rule exclusive remedy florida FMLA glossary check health care Healthcare iowa leadership medical medicare minnesota NCCI new jersey new york ohio osha pennsylvania Safety state info technology tennessee texas violence virginia WDYT west virginia what do you think women's history month workers' comp 101 workers' recovery workers' compensation contact information Workplace Safety Workplace Violence


  • Read Also

    About The Author

    • Mark Pew

      Mark Pew is a passionate educating and agitating thought leader in workers’ compensation and award-winning international speaker, blogger, author and jurisdictional advisor. He has focused on the intersection of chronic pain and appropriate treatment since 2003. He is the driving force and co-founder of The Transitions and just recently launched The RxProfessor consulting practice at https://therxprofessor.com.

    Read More

    Request a Demo

    To request a free demo of one of our products, please fill in this form. Our sales team will get back to you shortly.